APA (7th ed.) Citation

Chafiq Hamdouchi, P. M. (2018). Discovery of LY3104607: A Potent and Selective G Protein-Coupled Receptor 40 (GPR40) Agonist with Optimized Pharmacokinetic Properties to Support Once Daily Oral Treatment in Patients with Type 2 Diabetes Mellitus. American Chemical Society (ACS).

Chicago Style (17th ed.) Citation

Chafiq Hamdouchi, Pranab Maiti. Discovery of LY3104607: A Potent and Selective G Protein-Coupled Receptor 40 (GPR40) Agonist with Optimized Pharmacokinetic Properties to Support Once Daily Oral Treatment in Patients with Type 2 Diabetes Mellitus. American Chemical Society (ACS), 2018.

MLA (9th ed.) Citation

Chafiq Hamdouchi, Pranab Maiti. Discovery of LY3104607: A Potent and Selective G Protein-Coupled Receptor 40 (GPR40) Agonist with Optimized Pharmacokinetic Properties to Support Once Daily Oral Treatment in Patients with Type 2 Diabetes Mellitus. American Chemical Society (ACS), 2018.